Pharmacoeconomic Analysis of Axitinib as Second-Line Treatment for Metastatic Renal Cell Carcinoma
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2299
https://www.valueinhealthjournal.com/article/S1098-3015(14)04229-6/fulltext
Title :
Pharmacoeconomic Analysis of Axitinib as Second-Line Treatment for Metastatic Renal Cell Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04229-6&doi=10.1016/j.jval.2014.08.2299
First page :
A638
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1756